SCHEMBL14335796

SCHEMBL14335796

CC1CN(C(=O)Nc2nccs2)CCN1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.49
▸ MAPT P10636 1/20 0.46
▸ GAA P10253 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ FAAH O00519 2/20 0.42
▸ MAPKAPK2 P49137 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28473283 0.84 CYP2D6 (0.55) CYP2D6MAPTSMN1; SMN2NPC1HPGD
SCHEMBL16178782 0.81 CYP3A4 (0.38) CYP2D6MAPTALDH1A1EPHX2TSHR
SCHEMBL15070490 0.79 MAPT (0.63) CYP2D6MAPTGAASMN1; SMN2NPC1
SCHEMBL4231324 0.77 CYP2D6 (0.55) CYP2D6MAPTGAASMN1; SMN2NPC1
SCHEMBL2844451 0.76 SMN1; SMN2 (0.57) CYP2D6SMN1; SMN2NPC1FAAHKDM4E
SCHEMBL7890248 0.71 POLB (0.66) CYP2D6MAPTSMN1; SMN2NPC1HPGD
SCHEMBL16178755 0.71 NTRK1 (0.40) MAPTGAASMN1; SMN2ALDH1A1POLB
SCHEMBL16178737 0.71 RAB9A (0.44) MAPTSMN1; SMN2NPC1HPGDKDM4E
SCHEMBL16178505 0.70 RAB9A (0.57) MAPTGAASMN1; SMN2NPC1FAAH
SCHEMBL16178796 0.70 KDM4E (0.35) MAPTSMN1; SMN2NPC1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2723732-A1 TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF Purdue Pharma LP (US) 2014-04-30 — — EP disclosed
WO-2012176061-A9 TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF PURDUE PHARMA L.P. (US) 2013-03-14 — — WO disclosed
WO-2012176061-A1 TRPV1 ANTAGONISTS INCLUDING DIHYDROXY SUBSTITUENT AND USES THEREOF PURDUE PHARMA L.P. (US) 2012-12-27 — — WO disclosed
Send feedback